COLL - Collegium Pharmaceutical EPS beats by $0.11 beats on revenue May, 06 2021 04:40 PM Collegium Pharmaceutical Inc. Collegium Pharmaceutical (COLL): Q1 GAAP EPS of $0.41 beats by $0.11.Revenue of $87.72M (+14.7% Y/Y) beats by $6.09M.Press Release For further details see: Collegium Pharmaceutical EPS beats by $0.11, beats on revenue